Panome Bio and TD2 Oncology Forge Strategic Partnership to Enhance Oncology Research with Multi-Omics Integration#United_States#St._Louis#oncology_research#Panome_Bio#TD2_Oncology
Panome Bio and TD2 Oncology Forge Strategic Partnership to Enhance Oncology Research with Multi-Omics Integration
Panome Bio and TD2 Oncology expand their collaboration to interlink translational oncology with advanced multi-omics profiling, enhancing cancer research and drug development.
third-news.com
May 27, 2026 at 12:28 PM
Panome Bio and TD2 Oncology Forge Strategic Partnership to Enhance Oncology Research with Multi-Omics Integration#United_States#St._Louis#oncology_research#Panome_Bio#TD2_Oncology